Page 18 - RxExam's Naplex Theory Book Part 2
P. 18

www.pharmacyexam.com                                                                   Krisman


                                Dose               Special Notes

                Pegloticase                        2). Pegloticase (Krystexxa) is a pegylated uric acid specific enzyme
                (Injection)                        indicated for the treatment of chronic gout in adult patients refractory
                                                   to conventional therapy. Gout refractory to conventional therapy
                                                   occurs in patients who have failed to normalize serum uric acid and
                                                   whose signs and symptoms are inadequately controlled with xanthine
                                                   oxidase inhibitors at the maximum medically appropriate dose or for
                                                   whom these drugs are contraindicated. It is NOT recommended for the
                                                   treatment of asymptomatic hyperuricemia.

                                                   3). Patients should receive pre-infusion medications (e.g.
                                                   antihistamines, corticosteroids, acetaminophen), to minimize the risk of
                                                   anaphylaxis and infusion reactions.

                                                   4). Anaphylaxis and infusion reactions have been reported to occur
                                                   during and after administration of Pegloticase (Krystexxa). Anaphylaxis
                                                   may occur with any infusion, including a first infusion, and generally
                                                   manifests within 2 hours of the infusion. However, delayed type
                                                   hypersensitivity reactions have also been reported.

                                                   5). The risk of anaphylaxis and infusion reactions is higher in patients
                                                   who have lost therapeutic response. Monitor serum uric acid levels
                                                   prior to infusions and consider discontinuing treatment if levels
                                                   increase to above 6 mg/dL, particularly when 2 consecutive levels
                                                   above 6 mg/dL are observed.

                                                   6). Infusion site reactions, gout flares, urticaria, dyspnea, chest
                                                   discomfort, chest pain, erythema and pruritus are also reported with
                                                   the therapy.

                C). Uric Acid Excretion Enhancer

                Probenecid      1. Gout:           1). Probenecid is a uricosuric and renal tubular blocking agent. It
                (Tablet)        250 mg PO BID for  inhibits the tubular reabsorption of urate, thus increasing the urinary
                                1 week followed    excretion of uric acid and decreasing serum urate levels. Effective
                                by 500 mg PO BID   uricosuria reduces the miscible urate pool, retards urate deposition,
                                thereafter.        and promotes resorption of urate deposits.

                                                   2). Probenecid is indicated for:

                                                   a). For treatment of the hyperuricemia associated with gout and gouty
                                                   arthritis.
                                                   b). As an adjuvant to therapy with penicillin or with ampicillin,
                                                   methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and
                                                   prolongation of plasma levels by whatever route the antibiotic is given.



                                                             17
   13   14   15   16   17   18   19   20   21   22   23